Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Amortization of Deferred Charges (2016 - 2025)

Mimedx's Amortization of Deferred Charges history spans 14 years, with the latest figure at $135000.0 for Q1 2025.

  • On a quarterly basis, Amortization of Deferred Charges rose 95.65% to $135000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $352000.0, a 16.19% decrease, with the full-year FY2023 number at $505000.0, up 8.14% from a year prior.
  • Amortization of Deferred Charges hit $135000.0 in Q1 2025 for Mimedx, up from $16000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for MDXG hit a ceiling of $415000.0 in Q1 2021 and a floor of $16000.0 in Q3 2024.
  • Historically, Amortization of Deferred Charges has averaged $124714.3 across 5 years, with a median of $111500.0 in 2021.
  • Biggest five-year swings in Amortization of Deferred Charges: crashed 85.59% in 2024 and later surged 95.65% in 2025.
  • Tracing MDXG's Amortization of Deferred Charges over 5 years: stood at $112000.0 in 2021, then grew by 6.25% to $119000.0 in 2022, then increased by 10.92% to $132000.0 in 2023, then tumbled by 87.88% to $16000.0 in 2024, then soared by 743.75% to $135000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for MDXG at $135000.0 in Q1 2025, $16000.0 in Q3 2024, and $69000.0 in Q1 2024.